Wim Quint

DDL Diagnostic Laboratory

Papers

1

Total Citations

83

H-Index

1

About

Wim Quint is a leading figure in molecular virology, best known for his pioneering work in human papillomavirus (HPV) genotyping and its application to cervical cancer prevention. His research centers on the development and validation of PCR-based methods for detecting and differentiating HPV genotypes, which are critical for understanding viral carcinogenesis and improving screening strategies. A standout contribution is his highly cited 2008 study comparing two consensus primer PCR genotyping methods, which provided essential data on the accuracy and reliability of HPV detection techniques. This work, drawing on specimens from the landmark NCI/Costa Rica HPV16/18 vaccine trial, has garnered over 80 citations and helped shape clinical guidelines for HPV testing. Quint’s efforts have directly advanced the global fight against cervical cancer by enabling more precise risk stratification and vaccine efficacy monitoring. His rigorous methodological approach and commitment to translational research make him a respected authority in the field, whose insights continue to guide both laboratory practice and public health policy.

Research Focus

Key Achievements

1
H-Index
1
Papers
83
Total Citations
83
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of Two PCR-Based Human Papillomavirus Genotyping Methods
83 citations · 2008
📈 Most Prolific Year: 2008 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: DDL Diagnostic Laboratory

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago